Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Rath

Showing results (21-30 of 92) with videos related to

Pageof 10
Sort By:
Current Pharmaceutical Design|April 19, 2023
Targeting of SOS1: from SOS1 Activators to Proteolysis Targeting ChimerasGerhard Hamilton, Sandra Stickler, Barbara Rath
Translational Lung Cancer Research|May 17, 2023
Significance of circulating tumor cells in lung cancer: a narrative reviewGerhard Hamilton, Barbara Rath, Sandra Stickler
Expert Opinion on Drug Metabolism & Toxicology|March 4, 2015
Pharmacokinetics of crizotinib in NSCLC patientsGerhard Hamilton, Barbara Rath, Otto Burghuber
Current Drug Safety|April 11, 2015
Teaching vaccine safety communication to medical students and health professionalsBarbara Rath, Susann Muhlhans, Gerhard Gaedicke
Journal of Cancer|August 19, 2017
In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell LinesLukas Klameth, Barbara Rath, Gerhard Hamilton
Translational Lung Cancer Research|July 25, 2015
Chitinase-3-like-1/YKL-40 as marker of circulating tumor cellsGerhard Hamilton, Barbara Rath, Otto Burghuber
Current Drug Safety|April 11, 2015
Vaccine safety monitoring systems in developing countries: an example of the Vietnam modelMohammad Ali, Barbara Rath, Vu Dinh Thiem
Translational Lung Cancer Research|March 10, 2016
Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cellsGerhard Hamilton, Barbara Rath, Sophia Holzer, et al.
Oncoscience|September 2, 2015
Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancerGerhard Hamilton, Barbara Rath, Lukas Klameth, et al.
Marine Drugs|October 17, 2018
Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell LinesBarbara Rath, Maximilian Hochmair, Adelina Plangger, et al.
Pageof 10

Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Current Pharmaceutical Design|April 19, 2023
Targeting of SOS1: from SOS1 Activators to Proteolysis Targeting ChimerasGerhard Hamilton, Sandra Stickler, Barbara Rath
Translational Lung Cancer Research|May 17, 2023
Significance of circulating tumor cells in lung cancer: a narrative reviewGerhard Hamilton, Barbara Rath, Sandra Stickler
Expert Opinion on Drug Metabolism & Toxicology|March 4, 2015
Pharmacokinetics of crizotinib in NSCLC patientsGerhard Hamilton, Barbara Rath, Otto Burghuber
Current Drug Safety|April 11, 2015
Teaching vaccine safety communication to medical students and health professionalsBarbara Rath, Susann Muhlhans, Gerhard Gaedicke
Journal of Cancer|August 19, 2017
In vitro Cytotoxic Activities of the Oral Platinum(IV) Prodrug Oxoplatin and HSP90 Inhibitor Ganetespib against a Panel of Gastric Cancer Cell LinesLukas Klameth, Barbara Rath, Gerhard Hamilton
Translational Lung Cancer Research|July 25, 2015
Chitinase-3-like-1/YKL-40 as marker of circulating tumor cellsGerhard Hamilton, Barbara Rath, Otto Burghuber
Current Drug Safety|April 11, 2015
Vaccine safety monitoring systems in developing countries: an example of the Vietnam modelMohammad Ali, Barbara Rath, Vu Dinh Thiem
Translational Lung Cancer Research|March 10, 2016
Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cellsGerhard Hamilton, Barbara Rath, Sophia Holzer, et al.
Oncoscience|September 2, 2015
Receptor tyrosine kinase expression of circulating tumor cells in small cell lung cancerGerhard Hamilton, Barbara Rath, Lukas Klameth, et al.
Marine Drugs|October 17, 2018
Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell LinesBarbara Rath, Maximilian Hochmair, Adelina Plangger, et al.
Pageof 10